Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05614128 · ClinicalTrials.gov registry record
Validation of Cutaneous Nerve Demyelination in Diagnosis and Treatment of CIDP
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Terminated
- Registry status
- 2
- Enrollment target
NCT05614128 is a clinical trial that was terminated before completion, run by Vanderbilt University Medical Center. The registered enrollment target is 2 participants.
The verdict
NCT05614128 was terminated before completion, sponsored by Vanderbilt University Medical Center.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
The goal of this observational study is to learn about chronic inflammatory demyelinating polyneuropathy. The main question the investigators would like to answer is 1) can skin biopsy identify demyelination better than nerve conduction studies (electrical tests of the nerves)? and 2) how do nerves improve after treatment in CIDP? Participants will be asked to undergo skin biopsy of the finger at baseline and at 3 months and 6 months after treatment with IVIG (which is the FDA approved treatment for CIDP).
Interventions
- OTHER IVIg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2023-02-28 |
| Est. Completion | 2024-09-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05614128
The ClinicalTrials.gov registry entry for NCT05614128 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which IVIg is the first listed.
NCT05614128 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05614128 about?
NCT05614128 is a clinical study titled "Validation of Cutaneous Nerve Demyelination in Diagnosis and Treatment of CIDP". The goal of this observational study is to learn about chronic inflammatory demyelinating polyneuropathy. The main question the investigators would like to answer is 1) can skin biopsy identify demyelination better than nerve conduction studies (electrical tests of the nerves)? and 2) how do nerves ...
What is the current status of trial NCT05614128?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2023-02-28. Estimated completion is 2024-09-19.
What interventions are being tested in trial NCT05614128?
The interventions under investigation include: IVIg (OTHER).
Who is sponsoring clinical trial NCT05614128?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.